Amarin

AMRNNasdaq Ireland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$289.805 M

$13.72 -0.22%

Close of 23 Sept 2026

Revenue

$213.6M

#2265 by revenue

Earnings

-$38.8M

Loss-making

Shares outstanding

420,044,022

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#234Perspective TherapeuticsCATX$299.1M
#235Fulcrum TherapeuticsFULC$290.7M
#236AmarinAMRN$289.8M
#237InflaRxIFRX$288.8M
#238AC ImmuneACIU$288.0M

What if Amarin were worth as much as…

Open the what-if tool →

Gold $29.8T

$1,413,017

Per share 102,990× higher

Bitcoin $1.69T

$80,203.27

Per share 5,846× higher

Nvidia $5.43T

$257,294.59

Per share 18,753× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Amarin are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.